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Background: Immediate reconstruction of the breast can be performed in selected cases after
mastectomy for breast cancer or after prophylactic mastectomy in patients with a high risk of
developing breast cancer. Despite the frequency with which these procedures are performed, data
from large series of subpectoral implantation of silicone prostheses in combination with a skin-
saving approach are lacking.
Methods: In this retrospective study, data on complications and late surgical interventions in 356
patients who underwent 510 mastectomies with an inverted drip incision and immediate reconstruc-
tion (MIDIIR) were analyzed to determine potential prognostic factors of early complications.
Results: In 82% of the MIDIIRs, the postoperative course was uneventful. In 18%, the compli-
cations were infection (32 cases), necrosis of the skin flap (29 cases), bleeding (31 cases), and
protrusion of the prosthesis (20 cases), resulting in surgery in 9, 12, 15, and 20 cases, respectively.
At the end of the follow-up period, 30 (6%) prostheses were definitively removed. Age, size of the
prostheses, radiotherapy, previous lumpectomy, and indication for mastectomy were not significant
factors for the prognosis of early complications.
Conclusions: With the right technique and indications, MIDIIR is a very safe procedure and
should be one of the surgical treatments that can be offered in the overall management of patients
with, or at high risk for, breast cancer.
Key Words: Breast cancer—Mastectomy—Reconstruction—Silicone prosthesis—Skin-sparing
incision—Complications.
In the 19th century, mastectomy was performed only
in patients with bulky or ulcerating breast cancers, and
the local control rate was very low. For instance, be-
tween 1867 and 1876, Billroth1 performed 170 mastec-
tomies, and the local recurrence rate was 82%. When
Halsted2 introduced the principle of radical surgery for
breast cancer by combining a simple mastectomy with
resection of both pectoral muscles and an en-bloc axil-
lary node dissection (also for less-advanced stages), the
local control rate improved considerably. Between 1889
and 1894 in 50 patients, the rate was 6% but later
increased to 32% when the same group was studied again
in 1931.3 This radical mastectomy principle was subse-
quently modified, first by saving the minor pectoral
muscle and later by saving both pectoral muscles, with-
out loss of local control being more than 90%.4–7
In selected patients, radiotherapy of the chest wall is
indicated, e.g., in case of irradical resection or extensive
axillary of the chest wall and extensive axillary lymph
node metastases.8 In recent decades, attention has fo-
cused on improving other important issues for breast
cancer patients, e.g., from a surgical viewpoint, by im-
proving cosmesis. Nowadays it is generally accepted that
conservative surgery and radiotherapy is an excellent
alternative for modified radical mastectomy, also leading
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to better patient acceptance and psychosocial effects.9,10
Subsequent analyses of trials with breast-conserving
therapy resulted in better selection criteria for patients
with a relatively high local recurrence rate and thus not
recommended for breast-conserving therapy (e.g., related
to irradical lumpectomy, age, or extensive ductal
carcinoma-in-situ).11,12
Patients that are recommended to undergo a mastec-
tomy can be offered a delayed or immediate breast re-
construction (Fig. 1). The main disadvantage of delayed
reconstruction is the period of unnecessary mutilation
and the relative loss of skin that also has to be
reconstructed.
Immediate reconstruction of the breast must be a safe
oncological procedure that does not lead to an increased
number of local recurrences compared with mastectomy
alone. After a MEDLINE search, Malata et al.13 con-
cluded that there is no evidence that immediate recon-
struction is associated with higher recurrence rates or
interferes with the physical examination during follow-
up. Of all available methods for immediate reconstruc-
tion, the reconstruction with a subpectoral prosthesis
allows the same properties in chest wall palpation as
without a prosthesis. The recurrence rate seems to cor-
relate with the tumor stage and biological properties of
the breast cancer.14 Outcome was very similar for pre-
and postmenopausal patients and seemed independent of
lymph node status.15 Moreover, an immediate breast
reconstruction was shown not to influence subsequent
therapy, because adjuvant chemotherapy does not in-
crease the complication rate.16
Whether the skin-sparing incision is safe has not yet
been investigated in a randomized phase III study; pub-
lished data are mainly based on personal experience.
Carlson et al.17 compared their series of 188 patients
undergoing skin-sparing mastectomy with a historical
control group of 327 patients with mastectomy alone and
concluded that the local recurrence rate was similar in
both groups (4.8% vs. 9.5%, respectively, after a median
follow-up of 41 months). This conclusion was confirmed
by others: Slavin et al.18 investigated 114 native skin
flaps and found no evidence for the presence of ducts in
the resection margins, whereas Gabka et al.19 stressed the
need for experience in performing this procedure to
achieve these results.
Developments in the clinical genetics of breast cancer
and the discovery of the BRCA genes give women at high
risk a choice between intensive surveillance or prophy-
lactic mastectomy. In our clinic, women who choose
prophylactic mastectomy are offered an immediate
breast reconstruction.
Whereas Halsted used a vertical scar, this was later
changed to a horizontal scar for modified radical mas-
tectomy because this horizontal approach enables the
surgeon to amputate the breast with wide exposure of the
lateral region and the axilla. The wound is usually tai-
lored by reducing the lateral and medial dog ears and
produces a “nice flat appearance.” Nevertheless, this scar
is ugly and creates some important problems in delayed
reconstructive surgery.
In 1990, when our department started immediate
breast reconstruction by placement of a subpectoral sil-
icone prosthesis after mastectomy, the matter of the scar
was also extensively discussed. Because we were trou-
bled by the transverse scar, we changed our approach. In
1992, for cosmetic reasons, we decided to use Halsted’s
original vertical scar but with some modifications: the
so-called skin-sparing inverted drip incision. The aim
of this study was to investigate the surgical results
(complications, corrections, or both) of mastectomy
by an inverted drip incision and immediate reconstruc-
tion (MIDIIR) and compare these results with other
data from the literature.
PATIENTS AND METHODS
Surgical Technique
The operation is performed by a surgeon and a plastic
surgeon with the patient in semisitting position, the el-
bow in flexion, and the hand positioned low on the back.
The previous aspiration tract or the incisional/excisional
biopsy should have been performed in the future vertical
region, which includes the nipple.8 The incision extends
from just above the nipple down to 1 to 2 cm above the
inframammary line (Fig. 2). If the previous scar of a
lumpectomy is too far away to include the vertical inci-
sion, a separate incision is made to remove the scar in
continuity with the breast tissue. Although somewhat
less accessible, a mastectomy is then performed with a
fiberoptic headlight and dissection by diathermia in the
avascular plane. Dissection of the axillary nodes for
staging purposes can usually be performed through this
FIG. 1. Photographs of two patients illustrating the surgical history
of mastectomy for breast cancer. Left: the right side shows the Halsted
incision, and the left side shows a modified mastectomy. Right: the
right side shows a lumpectomy and radiotherapy for breast-saving
therapy, and the left side shows an immediate reconstruction with a
subpectoral prosthesis after mastectomy.
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incision, but a separate incision may be needed if there is
inadequate access to the axillary vein. After mastectomy,
a subpectoral silicone implant (Cristalline Paragel;™
Laboratoire Eurosilicone, Apt, France) ranging from 150
to 600 mL is inserted through the greater pectoral mus-
cle. Great care is taken to dissect sufficiently far down
under the origin of the rectus abdominis muscle and
laterally under the serratus muscles, and sometimes even
part of the pectoralis minor. Two suction drains are
placed: one beneath the pectoral muscle and the other
under the skin layer. The skin is closed in layers, without
correcting the dog ears. Patients are scheduled for a
5-day stay. The suction drains are removed after produc-
tion of 20 mL of drain fluid on two consecutive days.
The operation is performed under prophylactic antibiotic
and subcutaneous anticoagulant administration. Nipple
reconstruction is offered after 6 months.
Study Population
All women who underwent an MIDIIR at the Erasmus
Medical Center/Daniel den Hoed Cancer Clinic between
January 1992 and August 2001 were included in this
study. All medical records of these patients were re-
viewed (mean follow-up, 63 months; range, 3–116
months). For logistical reasons, the postoperative course
was divided into two periods: an early period (6
weeks) to identify postoperative complications and their
related surgical interventions and a late period (6
weeks) to identify subsequent surgical interventions for
cosmetic reasons. Study parameters were age at the time
of surgery, indication for MIDIIR, unilateral or (staged)
bilateral mastectomy, previous lumpectomy, radiother-
apy, size of the implant, early postoperative complica-
tions (within 6 weeks), and surgical interventions for
cosmetic corrections (after 6 weeks).
Statistical Analysis
Data were analyzed with the statistical program
Stata™ version 7.0 (Stata Corp., College Station, TX).
Comparisons of percentages were made by using the 2
test. Continuous data were compared by using the Mann-
Whitney U-test. A P value of .05 was considered
significant. The prognostic factors investigated in rela-
tion to complications occurring 6 weeks after surgery
were age at MIDIIR (45 vs. 45 years), indication for
MIDIIR (breast cancer vs. prophylactic), previous
lumpectomy (before mastectomy), size of the prosthesis,
and radiotherapy (only for recurrence after breast-saving
therapy).
RESULTS
Patient Characteristics
From January 1992 to August 2001, 356 patients un-
derwent 510 MIDIIRs. Bilateral MIDIIR was performed
in 77 patients (154 MIDIIRs: 140 MIDIIRs were per-
formed synchronously, and 14 MIDIIRs were performed
metachronously). The median age at MIDIIR was 43
years (range, 26–66 years; Table 1).
The indications for MIDIIR are listed in Table 1. Most
patients (n 239) were treated for breast cancer and had
either modified radical mastectomy (n  207) or recur-
rent breast cancer after breast-saving therapy (n  32).
Prophylactic mastectomy followed by immediate re-
construction was performed in 241 asymptomatic
women at high risk of breast cancer (159 with BRCA1,
23 with BRCA2, and 59 with hereditary breast ovarian
cancer). In 104 women, there was no history of breast
cancer, whereas 30 women were previously treated for
(non)invasive breast cancer. Thirty MIDIIRs were per-
formed for miscellaneous reasons, including severe fi-
brocystic disease (n  3; bilateral) and anxiety about
contralateral breast cancer (especially in patients with
lobular carcinoma or dense mammography; n  24).
FIG. 2. The inverted drip incision, starting with a round edge just
above the nipple down to 1 to 2 cm above the inframammary fold, with
a sharp edge.
TABLE 1. Indications for MIDIIR from January 1992 to
August 2001 in 356 patients undergoing 510 mastectomies
Indication Total Unilateral Contralateral
BRCA1 159 87 72
BRCA2 23 12 11
HBOC 59 38 21
Recurrence after BST 32 15 17
Carcinoma 207 177 30
Miscellaneous 30 27 3
Total 510 356 154
BST, breast-saving therapy; HBOC, hereditary breast ovarian can-
cer; MIDIIR, mastectomy with inverted drip incision and immediate
reconstruction.
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Of the 239 patients who underwent MIDIIR for breast
cancer, 178 (74%) had a diagnostic lumpectomy before
mastectomy. Of the 510 MIDIIRs, a prosthesis of 150 to
200 mL was used in 16 cases, 220 to 300 mL in 64 cases,
350 to 400 mL in 222 cases, 420 to 500 mL in 203 cases,
and 600 mL in 5 cases.
Of the total of 356 women, 39 received radiotherapy
before or after MIDIIR: 32 patients were treated previ-
ously for breast cancer by breast-saving therapy involv-
ing radiation of the breast, and 7 patients received radio-
therapy on the chest wall after mastectomy according to
the guidelines in our institute after definitive pathologic
staging. In five cases, the patient urgently requested
mastectomy without removal of the nipple (three unilat-
eral and one bilateral).
Complications Within 6 Weeks
In the 356 women, 510 breast reconstructions were
monitored for complications over a median follow-up
period of 63 months (range, 3–116 months) after MIDIIR
(Table 2). In 419 reconstructions (82%), no complica-
tions were observed, whereas the remainder had one or
more of the following complications: infection (32 cas-
es), necrosis of the skin flap (29 cases), bleeding (31
cases), and protrusion of the prosthesis (20 cases), re-
sulting in surgery in 9, 12, 15, and 20 cases, respectively.
Thus, within 6 weeks after surgery, 56 patients who had
MIDIIRs (11%) underwent another surgical intervention.
In 7 of the 20 MIDIIR patients with prosthesis-related
surgery, the prosthesis was immediately replaced. This
means an early loss of prosthesis of 13 of 510 patients,
i.e., 2.5%.
Late Surgical Interventions After 6 Weeks
Surgical interventions occurring more than 6 weeks
after surgery were needed in 366 MIDIIRs (Table 2).
These were mainly related to cosmetic appearance, such
as nipple reconstruction (238 of the 366 cases), change of
prosthesis due to poor symmetry, and correction of scar
or dog ear. Of the 83 MIDIIRs for which the indication
was related to the prosthesis, in 20 cases the prosthesis
was removed. The indications for this were infection,
necrosis, or both (six cases) or severe capsular formation
(nine cases), whereas the request from three patients (two
bilateral) for definitive removal of the prosthesis (per-
sonal inconvenience) was not considered related to sur-
gery. In 53 cases, the prosthesis was replaced because of
poor cosmetic appearance, capsular formation, or both,
and in 10 cases, a new prosthesis was placed after early
removal.
During the entire follow-up period (3–116 months),
complications related to surgery resulted in a loss of
prosthesis in 30 cases (6%). Secondary breast reconstruc-
tion was performed in 15 cases: 5 by a new subpectoral,
5 by a subcutaneous prosthesis, and 5 by a pedicled
latissimus dorsi flap in combination with a prosthesis. At
the end of the follow-up period, the overall loss of
prosthesis was 18 (3.5%) of 510. Eighteen (5%) patients
with a unilateral MIDIIR requested reduction mammo-
plasty on the opposite side.
Prognostic Factors Related to Early Complications
The prognostic factors investigated in relation to com-
plications occurring 6 weeks after surgery were age at
MIDIIR (45 vs. 45 years), indication of MIDIIR
(breast cancer vs. prophylactic), previous lumpectomy
(before mastectomy), size of the prosthesis, and radio-
therapy (only for recurrence after breast-saving therapy;
Table 3). None of these prognostic factors was signifi-
cant (P  .05 in all cases).
DISCUSSION
In most cases, mastectomy is performed with a trans-
verse incision. However, when breast reconstruction is
attempted, the transverse scar gives considerable prob-
TABLE 2. Early complications (6 wk) and late surgical
interventions (6 wk) after 510 MIDIIRs
Variable
Total Conservative Surgical
Early
Infection 32 23 9
Necrosis 29 17 12
Bleeding 31 16 15
Prosthesis 20 – 13 removed
7 replaced
Late
Scar/dog ear 45 – 45
Nipple 238 – 238
Prosthesis 83 – 20 removed
53 replaced
10 new
MIDIIR, mastectomy with inverted drip incision and immediate
reconstruction.
TABLE 3. Prognostic factors for early complications (6
wk)
Variable Prognostic factor P value
Age 45 vs. 45 y .53
Indication Cancer vs. prophylaxis .64
Previous lumpectomy Yes vs. no .39
Size of the prosthesis 350 vs. 350 ml .10
Previous radiotherapy Yes/no .50
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lems. First, the scar itself contracts and may have to be
lengthened by (lateral) Z-plasty. Second, usually there is
an extension up to the median line that can never be
corrected. Last but not least, there is a three-dimensional
deficit caused by (overly) ample resection and secondary
contraction, which requires placement of a tissue ex-
pander or use of myocutaneous flaps. Ideally, the center
of the scar should give the most projection but unfortu-
nately is contracted, sometimes showing dilated scar
tissue. Finally, the transverse scar emphasizes the patch-
like appearance of the abdominal skin, contrasting with
the thoracic skin.
In reduction mammoplasty, some prefer the vertical
scar,20–22 whereas others have tried to develop tech-
niques with a short inframammary scar or a periareolar
incision.23–25 The advantages of the MIDIIR technique
are the following:
1. The upper dog ear gives a surplus in the region of the
future nipple, providing more projection.26
2. The lower dog ear is inverted after the suction drain
is connected, thus creating a natural inframammary fold.
3. Excising the nipple causes some skin loss in the
lower pole of the breast. This part is stretched by the
correctly positioned prosthesis. In a few months, a nicely
rounded form appears. This confirms the investigation of
van Egmond et al.,27 who compared the inframammary
scars of different types of mammary reductions and
concluded that it is the content that determines the final
length of the inframammary scar.
4. Because the inner scar (pectoral muscle) and the
outer scar (skin) cross each other, this is known as the
envelope technique. Apart from providing more stability
to pressure (Fig. 3), there are also advantages in perspec-
tive: cranially the woman can barely see the full length of
the vertical scar. Frontally the scar appears much smaller
because it follows the direction of the inframammary
fold and lies on the shadow side of the breast. The actual
length of the scar can be reduced by gathering the skin
with a continuous intradermal suture.
5. Although the appearance is usually very pleasing,
all options remain open: e.g., the nipple can be recon-
structed on the elevation of the upper dog ear, the sili-
cone implant can be used as a spacer and can be replaced
by (de-epithelized) flaps, and a contralateral reduction
can be performed with an identical vertical inframam-
mary scar, thus achieving more symmetry. Even if (for
whatever reason) the implant has to be removed, the
remaining vertical scar is less conspicuous and smaller
than the usual horizontal one.
Since the introduction of DNA testing for the detec-
tion of BRCA1/2 mutation carriers, many women now
consider a prophylactic mastectomy.27,28 In an attempt to
help these women in their free choice, our group decided
to offer them an immediate reconstruction after mastec-
tomy.29 By 1992, we considered that we had accumu-
lated sufficient experience with the surgical procedure
described previously, and the MIDIIR became a standard
surgical tool in our hospital.
The aim of this study was to investigate whether
MIDIIR is acceptable with regard to complications and
loss of prostheses. It is established that general factors,
such as obesity, previous radiotherapy, and smoking, can
contribute to complications in reconstructive sur-
gery,30–33 whereas other factors, such as the type and size
of the prosthesis, age, whether or not the indication is
cancer, complete muscle coverage of the prosthesis, and
inverted T type of incision, are still disputed.30,34,35
Therefore, the prognostic factors studied in our series
were age, implant size, previous lumpectomy in primary
breast cancer, radiotherapy, and type of indication. Al-
though none of these factors proved to be significant, a
comment is required concerning radiotherapy. An earlier
study by our group reported radiotherapy to be a negative
factor.36 Reasons for this disparity compared with our
present series may be improved patient selection, more
experience in performing the surgical procedure, and the
longer follow-up period in this study.
The complication rate in this series was 18%, which
compares well with the 8% to 24% reported by oth-
ers.34,37–41 At the end of the follow-up period, the pros-
thesis was definitively removed in 30 (6%) of the 510
cases, compared with 1% to 16% reported in the litera-
ture.30,33,35–39,42 In 15 of our cases, a secondary recon-
struction was performed.
For various reasons, 18 (5%) patients with a unilateral
MIDIIR requested mammoplasty of the opposite site.
FIG. 3. The envelope technique shows crossing of the skin incision
and the pectoralis incision. Subpectoral prosthesis is shown with ex-
tension under the rectus abdominis muscle and serratus muscles.
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This percentage is very low compared with others, who
reported that 50% of their patients underwent reduction
of the contralateral breast.33,43 We have no explanation
for this large difference.
In this study, no information was obtained about sub-
jective factors, such as cosmetic results and psychosocial
satisfaction (Fig. 4). These will be investigated prospec-
tively in our hospital; meanwhile, the results of our pilot
study on patient satisfaction have been published.44
Although we did not evaluate the costs of MIDIIR, it
has been estimated that immediate reconstruction is less
costly than delayed reconstruction because the latter re-
quires additional hospitalization and more complex re-
constructive procedures. It has been reported that the
delayed reconstruction can cost $5,100 to $10,600 more
than immediate reconstruction, irrespective of the type of
reconstruction.45,46
In summary, our experience is that MIDIIR is a safe
and quick procedure. MIDIIR in our hands had an ac-
ceptable complication rate and an acceptable rate of
definitive loss of prostheses. The envelope technique
allows placement of prostheses of up to 600 mL without
the use of a tissue expander. With this technique, another
reconstruction can be made after removal of the silicone
prosthesis. Regarding limitations, the MIDIIR is not the
method of choice for obese patients and those with large
breasts; to avoid a bad cosmetic result in these cases,
another reconstructive technique (such as transverse rec-
tus abdominis myocutaneous or latissimus dorsi flaps) is
recommended. Additional studies are required to deter-
mine the long-term cosmetic results of MIDIIR, espe-
cially in women with increasing weight and patients with
previous radiotherapy.
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